Gadoteridol SDS
Original MedChemExpress safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
PDFプレビュー
無料で閲覧・ダウンロード可能・登録やログインは不要です。
PDFを読み込み中…
Normalized SDS data & document analysis
RESDS derives the results below from this document’s extracted text and the site’s same-material index. Detected codes are not reclassified. “Not detected” does not mean “not present”; confirm the original PDF for safety-critical use.
GHS & transport evidence
ページ links show the first occurrence found in extracted text.
SDS 16-section coverage
16 section headings detected; 0 not detected by the parser.
Same-material SDS comparison
4 indexed 件の文書 · 4 publishers · 1 languages · 2 stated revisions · page range 6–7. This compares document metadata, not product equivalence.
| 発行元 | 改訂版 | 言語 | 国・地域 | ページ数 |
|---|---|---|---|---|
| Current MedChemExpress | 記載なし | 英語 | 記載なし | 6 |
| APExBIO | 記載なし | 英語 | 記載なし | 7 |
| Cayman Chemical | 11/05/2025 | 英語 | 米国 · OSHA | 7 |
| Sigma-Aldrich | 03/03/2018 · Version 5.1 | 英語 | 記載なし | 6 |
材料・文書仕様
- Material
- Gadoteridol
- 製品・グレード
- 記載なし
- 発行元
- MedChemExpress
- 国・地域
- 記載なし
- ファイル名
- 135_Gadoteridol_MedChemExpress_EN.pdf
- 文書の種類
- SDS
- CAS登録番号
- 120066-54-8
- 言語
- 英語
- 原本改訂日
- 記載なし
- ページ数
- 6
- ファイルサイズ
- 252 KB
- ダウンロード数
- 4
- 追加日
- 2026-09-13
Full document text
6ページ · 原文書の言語
Text extracted from the original PDF. ページ order and original wording are preserved; tables and symbols may differ from the PDF layout. Check the original PDF for safety-critical details.
ページ 1
安全データシート Inhibitors
改訂版 Date: Nov.-6-2023 • Print Date: Oct.-15-2025
1. PRODUCT AND COMPANY IDENTIFICATION Screening
1.1 Product identifier
製品名 : Gadoteridol Libraries Catalog No. : HY-B0933 CAS No. : 120066-54-8 •
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, manufacture of substances. Proteins 1.3 詳細 of the supplier of the safety data sheet
Company: MedChemExpress USA
Tel: 609-228-6898
Fax: 609-228-5909
E-mail: sales@medchemexpress.com
1.4 Emergency telephone number
Emergency 電話番号 #: 609-228-6898
2. HAZARDS IDENTIFICATION
2.1 Classification of the substance or mixture
Not a hazardous substance or mixture.
2.2 GHS Label elements, including precautionary statements
Not a hazardous substance or mixture.
2.3 Other hazards
None.
3. COMPOSITION/INFORMATION ON INGREDIENTS
3.1 Substances
別名: SQ-32692; Gd-HP-DO3A
Formula: C17H28GdN4O7
Molecular Weight: 557.68
CAS No. : 120066-54-8
4. FIRST AID MEASURES
4.1 説明 of first aid measures
Eye contact
Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids
with fingers to ensure adequate flushing. Promptly call a physician.
Skin contact
ページ 1 of 6 www.MedChemExpress.com
ページ 2
Rinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.
Inhalation
Immediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-
to-mouth resuscitation.
Ingestion
Wash out mouth with water; Do NOT induce vomiting; call a physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2).
4.3 Indication of any immediate medical attention and special treatment needed
Treat symptomatically.
5. FIRE FIGHTING MEASURES
5.1 Extinguishing media
Suitable extinguishing media
Use water spray, dry chemical, foam, and carbon dioxide fire extinguisher.
5.2 Special hazards arising from the substance or mixture
During combustion, may emit irritant fumes.
5.3 Advice for firefighters
Wear self-contained breathing apparatus and protective clothing.
6. ACCIDENTAL RELEASE MEASURES
6.1 Personal precautions, protective equipment and emergency procedures
Use full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate
personnel to safe areas.
Refer to protective measures listed in sections 8.
6.2 Environmental precautions
Try to prevent further leakage or spillage. Keep the product away from drains or water courses.
6.3 Methods and materials for containment and cleaning up
Absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and
equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.
6.4 Reference to other sections
For disposal see section 13.
7. HANDLING AND STORAGE
7.1 Precautions for safe handling
Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust
ventilation.
7.2 Conditions for safe storage, including any incompatibilities
Keep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.
おすすめ storage temperature: Powder -20°C 3 years
4°C 2 years
ページ 2 of 6 www.MedChemExpress.com
ページ 3
In solvent -80°C 6 months
-20°C 1 month Shipping at room temperature if less than 2 weeks.
7.3 Specific end use(s)
No data available.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1 Control parameters
Components with workplace control parameters
This product contains no substances with occupational exposure limit values.
8.2 Exposure controls
Engineering controls
Ensure adequate ventilation. Provide accessible safety shower and eye wash station.
Personal protective equipment
Eye protection Safety goggles with side-shields.
Hand protection Protective gloves.
Skin and body protection Impervious clothing.
Respiratory protection Suitable respirator.
Environmental exposure controls Keep the product away from drains, water courses or the soil. Clean
spillages in a safe way as soon as possible.
9. PHYSICAL AND CHEMICAL PROPERTIES
9.1 Information on basic physical and chemical properties
Appearance Solid
Odor No data available
Odor threshold No data available
pH No data available
Melting/freezing point 188-193°C
Boiling point/range No data available
Flash point No data available
Evaporation rate No data available
Flammability (solid, gas) No data available
Upper/lower flammability or explosive limits No data available
Vapor pressure No data available
Vapor density No data available
Relative density No data available
Water Solubility No data available
Partition coefficient No data available
Auto-ignition temperature No data available
Decomposition temperature No data available
Viscosity No data available
Explosive properties No data available
ページ 3 of 6 www.MedChemExpress.com
ページ 4
Oxidizing properties No data available
9.2 Other safety information
No data available.
10. STABILITY AND REACTIVITY
10.1 Reactivity
No data available.
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
No data available.
10.4 Conditions to avoid
No data available.
10.5 Incompatible materials
Strong acids/alkalis, strong oxidising/reducing agents.
10.6 Hazardous decomposition products
Under fire conditions, may decompose and emit toxic fumes.
Other decomposition products - no data available.
11.TOXICOLOGICAL INFORMATION
11.1 Information on toxicological effects
Acute toxicity
Classified based on available data. For more details, see section 2
Skin corrosion/irritation
Classified based on available data. For more details, see section 2
Serious eye damage/irritation
Classified based on available data. For more details, see section 2
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
IARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or
confirmed human carcinogen by IARC.
ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed
carcinogen by ACGIH.
NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed
carcinogen by NTP.
OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed
carcinogen by OSHA.
Reproductive toxicity
ページ 4 of 6 www.MedChemExpress.com
ページ 5
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
Additional information
This information is based on our current knowledge. However the chemical, physical, and toxicological properties have not been
completely investigated.
12. ECOLOGICAL INFORMATION
12.1 Toxicity
No data available.
12.2 Persistence and degradability
No data available.
12.3 Bioaccumlative potential
No data available.
12.4 Mobility in soil
No data available.
12.5 検索結果 of PBT and vPvB assessment
PBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.
12.6 Other adverse effects
No data available.
13. DISPOSAL CONSIDERATIONS
13.1 Waste treatment methods
Product
Dispose substance in accordance with prevailing country, federal, state and local regulations.
Contaminated packaging
Conduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.
14. TRANSPORT INFORMATION
DOT (US)
Proper shipping name: Not dangerous goods
UN number: -
Class: -
Packing group: -
IMDG
Proper shipping name: Not dangerous goods
ページ 5 of 6 www.MedChemExpress.com
ページ 6
UN number: -
Class: -
Packing group: -
IATA
Proper shipping name: Not dangerous goods
UN number: -
Class: -
Packing group: -
15. REGULATORY INFORMATION
SARA 302 Components:
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components:
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis)
reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards:
No SARA Hazards.
Massachusetts Right To Know Components:
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components:
No components are subject to the Pennsylvania Right to Know Act.
New Jersey Right To Know Components:
No components are subject to the New Jersey Right to Know Act.
California Prop. 65 Components:
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive
harm.
16. OTHER INFORMATION
Copyright 2025 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to
be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must
only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of
safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from
handling or from contact with this product.
Caution: Product has not been fully validated for medical applications. For research use only.
Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@MedChemExpress.com
住所: 1 Deer Park Dr, Suite F, Monmouth Junction, NJ 08852, USA
ページ 6 of 6 www.MedChemExpress.com
同一材料:他の発行元によるSDS
3 件の文書がこの材料索引にあります。製品グレード、水和状態、配合は各原本PDFで確認してください。
原発行元・企業情報
- ブランド・組織
- MedChemExpress (MCE)
- 国・地域/事業所
- 米国
- ウェブサイト
- medchemexpress.com
- SDS記載の連絡先メール
- sales@medchemexpress.com
- SDS記載の電話番号
- 609-228-6898
- 製品・参照番号
- Gadoteridol
Official MedChemExpress contact page verifies the U.S. headquarters, company name and sales/customer-service email.
抽出した供給元情報を表示
Details of the supplier of the safety data sheet
Company: MedChemExpress USA
Tel: 609-228-6898
Fax: 609-228-5909
E-mail: sales@medchemexpress.comRESDSについて MedChemExpress USA
Official MedChemExpress contact page verifies the U.S. headquarters, company name and sales/customer-service email.
Company website & profile文書の出典・収録履歴
原登録: Gadoteridol — 安全データシート — MedChemExpress
追加日: 2026-09-13T12:49:04.000Z · 登録更新: 2026-09-14T04:27:05.267Z
原本ファイル SHA-256: 168c476c2560cc87bc5743ebb32be3619ebfbd55af220cb9cfddcc24084ed64a
原典PDF訂正・文書更新を依頼
メタデータの誤り、抽出エラー、供給元による新版、権利上の問題を報告できます。報告内容は運営者が確認するため非公開で保存され、送信しただけで公開中のSDSが直ちに変更されることはありません。
報告内容と任意のメールアドレスは、対応のため非公開で保存されます。サイト上には公開されません。機密情報や個人の重要情報を入力しないでください。
公式化学物質情報源
情報源ガイド ↗このSDSに記載されたCAS番号です。以下の性質は個々の物質に関するもので、製品全体を示すとは限りません。混合物、グレード、水和状態については原本SDSをご確認ください。
CAS 120066-54-8化学物質の参考情報・情報源リンク
CAS 120066-54-8 · CAS Common Chemistry ↗ · PubChem ↗
- 化学物質名(IUPAC)
- PubChemで確認 ↗
- 分子式
- PubChemで確認 ↗
- 分子量
- PubChemで確認 ↗
- 主な別名
- PubChemで確認 ↗
- 化学構造
- PubChemで構造を表示 ↗
この参考リンクを開くと、PubChemで公開されている物性情報を取得できます。公式検索リンクは引き続き利用できます。
ECHA CHEM · CAS番号を検索 120066-54-8 ↗ · AICISインベントリ · CAS番号を検索 120066-54-8 ↗
GHSは分類基準を示すものです。適用される危険有害性分類は、対象製品および各法域について個別に確認してください。
この材料の供給元
該当材料のSDSと公式製品ページから確認した企業です。グレード、組成、供給状況は供給元へ直接ご確認ください。確認できない連絡先は推測して掲載しません。
| Company | 国・地域 | ウェブサイト | メール | 電話番号 | Evidence |
|---|---|---|---|---|---|
| APExBIO | 記載なし | ウェブサイト | sales@apexbt.com | 記載なし | 情報源 Same material SDS; verify grade and availability |
| Cayman Chemical Co. | 米国 | ウェブサイト | 記載なし | 記載なし | 情報源 Same material SDS; verify grade and availability |
| Sigma-Aldrich | 米国 | ウェブサイト | 記載なし | +1 800-325-5832 | 情報源 Same material SDS; verify grade and availability |
ウェブでその他の供給元を検索
この材料を複数の検索エンジンで検索
検索語: Gadoteridol SDS
Wikipediaによる材料の基礎情報
Wikipediaで Gadoteridol を検索します。該当記事がある場合は概要を表示します。製品固有の混合物や標準物質には専用記事がない場合があります。
Wikipediaでこの材料を検索 ↗Wikipedia執筆者による概要: CC BY-SA 4.0. 一般的な材料情報であり、対象製品のSDSに代わるものではありません。